Pilot Study on the Effects of Intravenous Ketamine on Acute Pain Crisis in Patients With Sickle Cell Disease
Status:
Terminated
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this pilot study is to provide a preliminary assessment of the feasibility and
efficacy of intravenous ketamine in controlling pain in patients with sickle cell disease
(who are admitted to the hospital with severe, acute pain crisis, and who have been resistant
to intravenous narcotics).